Lomecel-B Effects on Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Longeveron Inc.
Related studies linked through entity extraction aliases.
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
- Status
- COMPLETED
- Phase
- PHASE2
Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
- Status
- WITHDRAWN
- Phase
- PHASE2
Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2